Compounds > nbi 27914
Page last updated: 2024-09-05

nbi 27914 and astressin-2b

nbi 27914 has been researched along with astressin-2b in 5 studies

Compound Research Comparison

Studies
(nbi 27914)		Trials
(nbi 27914)		Recent Studies (post-2010)
(nbi 27914)		Studies
(astressin-2b)		Trials
(astressin-2b)		Recent Studies (post-2010) (astressin-2b)
7602941030

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, Y; Neugebauer, V1
Guan, X; Li, S; Xu, Y; Zhang, R1
Abe, N; Amagase, K; Kamei, K; Kubo, Y; Kumano, A; Takeuchi, K1
Silberman, Y; Winder, DG1
Bagaeva, TR; Filaretova, LP; Iarushkina, NI1

Other Studies

5 other study(ies) available for nbi 27914 and astressin-2b

ArticleYear
Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Apr-09, Volume: 28, Issue:15

    Topics: Amygdala; Aniline Compounds; Animals; Arthritis; Behavior, Animal; Cyclic AMP-Dependent Protein Kinases; Electrophysiology; Enzyme Activation; Hindlimb; In Vitro Techniques; Neurons; Pain; Patch-Clamp Techniques; Peptide Fragments; Peptides, Cyclic; Potassium Channels; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reflex; Spinal Cord; Synapses; Tetraethylammonium; Vocalization, Animal

2008
Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of corticotropin-releasing factor receptor subtype 2.
    Neuroscience, 2009, Jul-07, Volume: 161, Issue:3

    Topics: Analysis of Variance; Aniline Compounds; Animals; Cocaine; Dopamine Uptake Inhibitors; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; Long-Term Potentiation; Male; Membrane Potentials; Microelectrodes; Neurons; Peptide Fragments; Peptides, Cyclic; Pyrimidines; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Substance Withdrawal Syndrome

2009
Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:6

    Topics: Aniline Compounds; Animals; Bacterial Translocation; Corticotropin-Releasing Hormone; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Gastrointestinal Motility; Indomethacin; Injections, Intravenous; Intestine, Small; Male; Nitric Oxide Synthase Type II; Peptic Ulcer; Peptide Fragments; Peptides, Cyclic; Peroxidase; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Time Factors; Urocortins

2010
Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala.
    Neuropharmacology, 2013, Volume: 70

    Topics: Adrenergic beta-Agonists; Amygdala; Aniline Compounds; Animals; Catecholamines; Corticotropin-Releasing Hormone; Dopamine; Excitatory Postsynaptic Potentials; Glutamic Acid; Isoproterenol; Male; Mice; Neurons; Peptide Fragments; Peptides, Cyclic; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Synaptic Transmission

2013
[Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2014, Volume: 100, Issue:11

    Topics: Analgesics; Aniline Compounds; Animals; Behavior, Animal; Consciousness; Corticotropin-Releasing Hormone; Gene Expression; Injections, Intraperitoneal; Male; Nociception; Nociceptive Pain; Peptide Fragments; Peptides, Cyclic; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone

2014